SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

ADC Therapeutics Q2 EPS $(2.01) Misses $(0.67) Estimate

ADC Therapeutics (NYSE:ADCT) reported quarterly losses of $(2.01) per share which missed the analyst consensus estimate of $(0.67) by 200 percent.

Benzinga · 08/18/2020 11:45
ADC Therapeutics (NYSE: ADCT) reported quarterly losses of $(2.01) per share which missed the analyst consensus estimate of $(0.67) by 200 percent.